The Patent Finder
NP

Nevakar Pharmaceuticals, Inc.

First filing 2018
OverviewNotableFeesChangesFamiliesPatent listSources & methods

10 patents currently held

Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

The next term ends in Jan 2038. from the record

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
Jan 2038
Next term end
1
Patent families

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
notable patents all others Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size.

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Mar 24, 2027
    The maintenance fee for Norepinephrine Compositions and Methods Therefor (US 10,420,735) comes due Mar 24, 2027. Unpaid by Sep 24, 2027, it lapses early.
  • 1 fee due May 12, 2027
    The maintenance fee for Norepinephrine Compositions and Methods Therefor (US 10,471,026) comes due May 12, 2027. Unpaid by Nov 12, 2027, it lapses early.
  • 1 fee due Aug 25, 2027
    The maintenance fee for Norepinephrine Compositions and Methods Therefor (US 10,568,850) comes due Aug 25, 2027. Unpaid by Feb 25, 2028, it lapses early.
  • 1 fee due Nov 12, 2027
    The maintenance fee for Norepinephrine Compositions and Methods Therefor (US 10,646,458) comes due Nov 12, 2027. Unpaid by May 12, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

What they patent

Grouped by real patent family, largest first, labeled by the earliest filing in each. No technology classification is inferred from titles.

Patents held now

Soonest term end first.

Showing 1 to 10 of 10

PatentTitleStatusExpiresConfidence
US 10,159,657Norepinephrine Compositions and Methods Therefor
In force
 · Medium confidence
In forceMedium confidence
US 10,226,436Norepinephrine Compositions and Methods Therefor
In force
 · Medium confidence
In forceMedium confidence
US 10,420,735Norepinephrine Compositions and Methods Therefor
In force
 · Medium confidence
In forceMedium confidence
US 10,471,026Norepinephrine Compositions and Methods Therefor
In force
 · High confidence
In forceHigh confidence
US 10,568,850Norepinephrine Compositions and Methods Therefor
In force
 · Medium confidence
In forceMedium confidence
US 10,646,458Norepinephrine Compositions and Methods Therefor
In force
 · High confidence
In forceHigh confidence
US 11,413,259Norepinephrine Compositions and Methods Therefor
In force
 · Medium confidence
In forceMedium confidence
US 11,602,508Norepinephrine Compositions and Methods Therefor
In force
 · Medium confidence
In forceMedium confidence
US 12,440,459Norepinephrine Compositions and Methods Therefor
In force
 · Medium confidence
In forceMedium confidence
US 12,245,996Norepinephrine Compositions and Methods Therefor
In force
 · Medium confidence
In forceMedium confidence
Also on record, not counted in the 10: 8 applications pending. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
2 terminal disclaimers are on file with no resolved reference. No cap is applied and none is guessed
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited